We report a rare case of pars planitis with progressive unilateral pigmentation of the retina. Unilateral RP (also called extremely asymmetrical RP) is a rare and controversial condition that has been described in the literature, but there are still doubts about its existence as an isolated clinical entity and its relation to RP. Some mechanisms purposed are the occurrence of genetic mosaics (mutations that affect only some of the cells) or somatic mutations (instead of germline mutations) [7, 8]. Since retinal dystrophies are usually bilateral due to their genetic background, a unilateral manifestation requires rule out other explanations.
The differential diagnosis for unilateral retinal pigment epithelium changes and peripheral field loss starts with asking for prior blunt trauma, retinal detachment or retained metallic intraocular foreign body. Treatment with antipsychotics from the group of phenothiazines can induce a peripheral pigmentary retinopathy [9]. Since our patient had no history of trauma or consumption of antipsychotics, this differential diagnosis could be excluded.
Some patients with cancer can develop antibodies against retinal antigens (antirecoverin antibodies), leading to a paraneoplastic syndrome called carcinoma-associated retinopathy or autoimmune retinopathy [10]. Since the autoantibodies circulate in the blood stream, BE are usually affected.
Retinal pigmentary changes can also occur in the context of past ocular infection or inflammatory eye disease. Syphilis, toxoplasmosis, cytomegalovirus, rubella, measles or diffuse unilateral subacute neuroretinitis (DUSN) must be ruled out [6]. They can occur uni or bilaterally, usually early in life. As described above, infections were excluded in our patient.
The patient was first diagnosed of pars planitis. Few publications of uveitis coexisting with RP have been reported, specially a form of non-granulomatous uveitis called Fuchs’ heterochromic iridocyclitis [11,12,13,14]. Dust-like particles in the vitreous are present in the great majority of young individuals with RP. These usually are fine, colorless particles comprising free melanin pigment granules, uveal melanocytes, EPR cells, and macrophage-like cells. These particles can be confused with vitreous cells or snowballs present in the intermediate uveitis. Particles in RP eyes are evenly distributed throughout the vitreous while the snowballs, larger in size, are observed at the bottom of the vitreous cavity. Observation of these small particles can be helpful in the diagnosis of early RP before pigmentary fundus changes are apparent. Our patient showed vitreous cells and snowballs in BE so that the observation of these dust-like particles in the LE was difficult.
The typical bone-spicule pigmentation represents migration of pigment into the interstitial spaces of the retina from disintegration of RPE cells. This pigment accumulation is greater in the surrounding spaces of the retinal vessels, producing perivascular pigmentary cuffing and spicule-shaped deposits. Almost all forms of RP go through a stage where no pigmentary changes exist in the retina. This stage may exist for decades before typical RP signs appear.
Pigmentation of the retina developed in only three months in our patient. Probably some grade of epithelitis developed in the left eye of our patient. We hypothesize that inflammation may accelerate the pass to the pigmentary stage. It is well known that inflammatory eye diseases like rubella, syphilis or DUSN present with pigmentary abnormalities within the retina [6]. Inflammation can promote a RPE cell reaction and stimulate the migration of the pigment into the retina. The pigment deposits are clumps or large patches of black pigment and can be associated to chorioretinal scars. Then, distribution of pigmentation due to inflammation is usually patched and typical bone-spicule pigment formations are uncommon.
In summary, an inflammatory process like pars planitis can accelerate the pigmentation of the retina. Asymmetrical RP must be ruled out in these unilateral RP-like appearance post-inflammatory changes.